1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
611F49FCD14687B03852584EE006CDD10
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/11F49FCD14687B03852584EE006CDD10?OpenDocument
18
19OpenDocument
203.226.72.118
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Document Excerpt: EU MSL Excellence: Optimizing resources for European field medical operations

DB Image

ID: MD-695


Features:

12 Info Graphics

16 Data Graphics

300+ Metrics

7 Narratives


Pages/Slides: 4


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "add to cart" on the right.


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5595 "EU MSL Excellence: Optimizing resources for European field medical operations".

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Chemical; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Alexion Pharmaceuticals; Allergopharma; Amgen; AstraZeneca; Bayer; Biogen; Bioventus; Boehringer Ingelheim; Celgene; Chiesi; Clovis Oncology; Dr Reddy's Laboratories; Eisai; Galderma; GE Healthcare; Gedeon Richter ; Gilead Sciences; Grifols; Ipsen; Janssen; Kiniksa Pharmaceuticals; Kyowa Kirin; Merck Serono; Merck; Novartis; Pfizer; Rakuten Medical; Roche; Sandoz; Sanofi; Lupin; Shire; Takeda Pharmaceuticals; Sunovion; UCB Pharma; Vertex Pharmaceuticals; Vifor Pharma; ViiV Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.